Sponsor Pipeline

Kumquat Biosciences Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
4
Recruiting
4
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-29 NCT06507306
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in…
Enrollment closed, study ongoing
2026-07-29 NCT06507306
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in…
Trial sites reduced: 35 -> 26 locations
Active Trials by Phase
Phase 2
1
Phase 1
6
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07406633 KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st… GIST - Gastrointestinal Stromal Tumor Recruiting
Phase 1
NCT06994806 A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in… Solid Tumor Malignancies Recruiting
NCT06720987 A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in… KRAS G12C Mutation Recruiting
NCT07207707 A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced… Solid Tumor Malignancies Recruiting
NCT06645886 A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in… Hematologic Malignancies Active, Not Recruiting
NCT07542704 A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants… Advanced Solid Tumors Not Yet Recruiting
NCT06507306 A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in… Solid Tumor, Adult Active, Not Recruiting
Disease Areas
Get alerts when Kumquat Biosciences Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free